🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being done to compare the combination of lenalidomide and dexa...
Status
Completed
Location
Columbia University
Start Date
2012-09
Trial ID
NCT01731886
This study aim to evaluate the effects of protein supplements and resistanc...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-07-01
Trial ID
NCT06950684
Treatments Being Tested
The objective of this Phase II, open-label, multicenter, non-randomised con...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01-01
Trial ID
NCT06692491
Treatments Being Tested
The Phase I part of the study will apply to identify dose-limiting toxiciti...
Status
Completed
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2011-11-09
Trial ID
NCT01458366
Treatments Being Tested
This study will evaluate the efficacy and safety of duvelisib in combinatio...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02576275
Treatments Being Tested
The existing evidence from epidemiological studies and randomized controlle...
Status
Completed
Location
Lewai S Abdulaziz
Start Date
2015-04-01
Trial ID
NCT04017845
This single-arm, open-label, Phase II study assesses first-line QL1706 + be...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing 100021
Start Date
2025-08-01
Trial ID
NCT07083375
Treatments Being Tested
The primary objective is to cure multiple myeloma with less toxic allogenei...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2001-08
Trial ID
NCT00854139
This research project addresses the urgent need for novel therapeutic strat...
Status
Not Yet Recruiting
Location
Duke Cancer Institute
Start Date
2025-04-01
Trial ID
NCT06620029
Treatments Being Tested
The investigators hypothesize that prophylactic E-selectin inhibition via a...
Status
Completed
Location
Washington University School of Medicine
Start Date
2021-05-05
Trial ID
NCT04682405
Treatments Being Tested